Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedDec 11, 2019fentaNYL 2750 mcg/55 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0558-2020Class IITerminatedDec 11, 2019fentaNYL 200 mcg/100 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0557-2020Class IITerminatedDec 11, 2019fentaNYL 100 mcg/2 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0556-2020Class IITerminatedDec 11, 2019fentaNYL 1000 mcg/100 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0555-2020Class IITerminatedDec 11, 2019fentaNYL 400 mcg/200 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0554-2020Class IITerminatedDec 11, 2019fentaNYL 2500 mcg/250 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0553-2020Class IITerminatedDec 11, 2019fentaNYL 500 mcg/250 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0552-2020Class IITerminatedDec 11, 2019fentaNYL 1500 mcg/30 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0551-2020Class IITerminatedDec 11, 2019fentaNYL 200 mcg/100 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0550-2020Class IITerminatedDec 11, 2019fentaNYL 500 mcg/250 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0549-2020Class IITerminatedDec 11, 2019fentaNYL 200 mcg/100 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0548-2020Class IITerminatedDec 11, 2019fentaNYL 500 mcg/250 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0547-2020Class IITerminatedDec 11, 2019fentaNYL 500 mcg/250 mLPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particulesQuVa Pharma, Inc. · D-0546-2020Class IIOngoingDec 11, 2019Zantac 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0545-2020Class IIOngoingDec 11, 2019Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0544-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0543-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0542-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0541-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0540-2020Class IIOngoingDec 11, 2019Maximum Strength Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0539-2020Class IIOngoingDec 11, 2019Cool Mint Maximum Strength Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0538-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0537-2020Class IIOngoingDec 11, 2019Maximum Strength Zantac 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0536-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0535-2020Class IIOngoingDec 11, 2019Cool Mint Tablets Maximum Strength Zantac 150 mg SanofiCGMP Deviations: Presence of NDMA impurity detected in product.Sanofi-Aventis U.S. LLC · D-0534-2020Class IITerminatedDec 11, 2019LETS GEL KIT Convenience PackMicrobial contamination of non-sterile product.Fagron, Inc · D-0533-2020Class IITerminatedDec 4, 2019Potassium PhosphateFailed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.Avantor Performance Materials Inc · D-0575-2020Class IITerminatedDec 4, 2019Lidocaine HCl InjectionPresence of Foreign Substance: Foreign material found inside the vial.AuroMedics Pharma LLC · D-0573-2020Class IITerminatedDec 4, 2019Ibuprofen Oral Suspension USPPresence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Preferred Pharmaceuticals, Inc · D-0531-2020Class IIOngoingDec 4, 2019Aurobindo Ranitidine Capsules 150 mgCGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.AuroMedics Pharma LLC · D-0530-2020Class IIOngoingDec 4, 2019Ranitidine SyrupCGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.AuroMedics Pharma LLC · D-0529-2020Class IIOngoingDec 4, 2019Aurobindo Ranitidine Capsules 300 mgCGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.AuroMedics Pharma LLC · D-0528-2020Class IIOngoingDec 4, 2019Aurobindo Ranitidine Caspules 150 mgCGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.AuroMedics Pharma LLC · D-0527-2020Class IIOngoingDec 4, 2019DG Health Acid Reducer Ranitidine Tablets 150 mgCGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.AuroMedics Pharma LLC · D-0526-2020Class IITerminatedDec 4, 2019AVKARE Ranitidine TabletsCGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in APIAVKARE Inc. · D-0525-2020Class IITerminatedDec 4, 2019AVKARE Ranitidine TabletsCGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in APIAVKARE Inc. · D-0524-2020Class IITerminatedDec 4, 2019Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection SolutionLack of sterility assurance.New Vitalis Pharmacy LLC dba New Vitalis Pharmacy · D-0523-2020Class IIITerminatedDec 4, 2019Amiodarone Hydrochloride InjectionCrystallization: Presence of visible particulate matter.AuroMedics Pharma LLC · D-0522-2020Class IIITerminatedDec 4, 2019Amiodarone Hydrochloride InjectionCrystallization: Presence of visible particulate matter.AuroMedics Pharma LLC · D-0521-2020Class IIITerminatedDec 4, 2019Amiodarone Hydrochloride InjectionCrystallization: Presence of visible particulate matter.AuroMedics Pharma LLC · D-0520-2020

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.